about
Comparison of the effects of DC031050, a class III antiarrhythmic agent, on hERG channel and three neuronal potassium channels.Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.Structural defects lead to dynamic entrapment in cardiac electrophysiology.LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5-mg Capsules After Single-Dose Administration in Healthy Subjects.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dofetilide, a new class III antiarrhythmic agent.
@ast
Dofetilide, a new class III antiarrhythmic agent.
@en
type
label
Dofetilide, a new class III antiarrhythmic agent.
@ast
Dofetilide, a new class III antiarrhythmic agent.
@en
prefLabel
Dofetilide, a new class III antiarrhythmic agent.
@ast
Dofetilide, a new class III antiarrhythmic agent.
@en
P2860
P1433
P1476
Dofetilide, a new class III antiarrhythmic agent.
@en
P2093
D E Hilleman
P2860
P304
P356
10.1592/PHCO.20.9.776.35208
P407
P577
2000-07-01T00:00:00Z